GenMark Diagnostics (GNMK) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
GenMark Diagnostics Reports Q2 Financial Results
August 6, 2015 4:05 PM EDTSecond Quarter Revenue of $7.6 Million, Up 17% Versus Prior Year
XT-8 Installed Base Expanded by 29 to 591
European ePlex Launch Expected by the End of Fourth Quarter 2015
Full Year Revenue Guidance Maintained at $38-40 Million; Gross Margin Increased to 57-59%
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported second quarter 2015 financial results.
Revenue for the second quarter of 2015 was $7.6 million,... More
